Degradation by the β-site APP cleavage enzyme (BACE1) via the amyloidogenic pathway results in the secretion of AICD and amyloid beta (Aβ), which is potentially associated with psychiatric symptoms and microcephaly in AD and ASD. Here, BACE1 is linked to microcephaly.